Join us for a conversation with Stewart Campbell, a global biopharmaceutical executive focused on translating scientific innovation into meaningful outcomes for patients.
Stewart is Chief Executive Officer of Novita Pharmaceuticals, where he is leading the development of Prilukae® (NP-G2-044), a first-in-class oncology therapy designed to prevent metastatic progression. Previously, he served as President and CEO of Ipsen North America and held senior global product strategy roles at Genentech/Roche, helping launch oncology medicines across more than 100 countries.
Having lived and worked across Canada, Europe, and the United States, Stewart brings a global perspective on leadership, innovation, and purpose-driven growth in life sciences. He now resides in the Boston area within one of the world’s most dynamic biotech communities.
We are encouraging all guests to please complete a short pre-qualification before the event: Qualification!